Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(15%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
10
77%
Ph phase_4
3
23%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution13 total trials
Phase 4Post-market surveillance
3(23.1%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(5)
Other(6)

Detailed Status

unknown6
Completed5
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (23.1%)
N/A10 (76.9%)

Trials by Status

active_not_recruiting18%
recruiting18%
completed538%
unknown646%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
13